Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PREDICT Gives FDA Head Start On Meeting House's Call For "Trade Facilitation"

Executive Summary

FDA's PREDICT system should enable the agency to comply with the intent, if not the particulars, of a House Appropriations Committee suggestion to facilitate entry into the United States of goods that pose little risk.
Advertisement

Related Content

Adjuvanted Flu Vaccines Get Booster: House Report Presses FDA On Approval
Separate FDA Safety Office Attached To House Report, Still Faces Steep Road
House Approps Bill Would "Harden" Science Requirements For FDA Rules, Guidance
FDA Will Have Risk-Based Import Screening System Up And Running Throughout U.S. By Year's End
FDA Will Have Risk-Based Import Screening System Up And Running Throughout U.S. By Year's End
High-Risk Drug Imports To Be Delayed, FDA PREDICTs; Focus On Data Quality Can Avoid New 20 Percent Dragnet

Topics

Advertisement
UsernamePublicRestriction

Register

PS053466

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel